Advertisement

Medical Therapy and Coronary Revascularization for Patients With Stable Coronary Artery Disease and Unclassified Appropriateness Score

Published:October 02, 2015DOI:https://doi.org/10.1016/j.amjcard.2015.09.020
      Although the appropriate use criteria incorporate common clinical scenarios for coronary revascularization, a significant proportion of patients with stable coronary artery disease (CAD) cannot be assigned an appropriateness score. Our objective was to characterize these patients and to evaluate whether coronary revascularization is associated with improved outcomes. A population-based cohort of patients aged ≥66 years, who underwent cardiac catheterization in Ontario, Canada, were included. Clinical characteristics were compared between patients with and without an appropriateness score. Clinical outcomes between coronary revascularization and medical therapy in patients with unclassified appropriateness score were compared using the inverse probability of treatment-weighted propensity method for confounder adjustment. Of the 19,228 patients with stable CAD, 11.2% (2,153 patients) were not assigned to an appropriateness score, mostly (92.9%) because of a lack of ischemic evaluation or a noninterpretable test. These patients were older, had higher rate of severe angina, and had more medical co-morbidities compared to patients with an appropriateness score. The 2-year rate of death or myocardial infarction in patients with unclassified appropriateness score was 15.3% in the revascularization group versus 20.7% in the medical therapy group. After propensity weighting, revascularization was associated with significantly lower hazard ratio (0.70; 95% confidence interval 0.61 to 0.79) for death or myocardial infarction compared with medical therapy. In conclusion, in patients aged ≥66 years with stable CAD and unclassified appropriateness score, revascularization is associated with improved outcomes.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ko D.T.
        • Chiu M.
        • Guo H.
        • Austin P.C.
        • Goeree R.
        • Cohen E.
        • Labinaz M.
        • Tu J.V.
        Safety and effectiveness of drug-eluting and bare-metal stents for patients with off- and on-label indications.
        J Am Coll Cardiol. 2009; 53: 1773-1782
        • Patel M.R.
        • Dehmer G.J.
        • Hirshfeld J.W.
        • Smith P.K.
        • Spertus J.A.
        ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography.
        J Am Coll Cardiol. 2012; 59: 857-881
        • Bradley S.M.
        • Maynard C.
        • Bryson C.L.
        Appropriateness of percutaneous coronary interventions in Washington state.
        Circ Cardiovasc Qual Outcomes. 2012; 5: 445-453
        • Chan P.S.
        • Patel M.R.
        • Klein L.W.
        • Krone R.J.
        • Dehmer G.J.
        • Kennedy K.
        • Nallamothu B.K.
        • Weaver W.D.
        • Masoudi F.A.
        • Rumsfeld J.S.
        • Brindis R.G.
        • Spertus J.A.
        Appropriateness of percutaneous coronary intervention.
        JAMA. 2011; 306: 53-61
        • Hannan E.L.
        • Cozzens K.
        • Samadashvili Z.
        • Walford G.
        • Jacobs A.K.
        • Holmes Jr., D.R.
        • Stamato N.J.
        • Sharma S.
        • Venditti F.J.
        • Fergus I.
        • King Iii, S.B.
        Appropriateness of coronary revascularization for patients without acute coronary syndromes.
        J Am Coll Cardiol. 2012; 59: 1870-1876
        • Ko D.T.
        • Tu J.V.
        • Austin P.C.
        • Wijeysundera H.C.
        • Samadashvili Z.
        • Guo H.
        • Cantor W.J.
        • Hannan E.L.
        Prevalence and extent of obstructive coronary artery disease among patients undergoing elective coronary catheterization in New York State and Ontario.
        JAMA. 2013; 310: 163-169
        • Tu J.V.
        • Bowen J.
        • Chiu M.
        • Ko D.T.
        • Austin P.C.
        • He Y.
        • Hopkins R.
        • Tarride J.E.
        • Blackhouse G.
        • Lazzam C.
        • Cohen E.A.
        • Goeree R.
        Effectiveness and safety of drug-eluting stents in Ontario.
        N Engl J Med. 2007; 357: 1393-1402
        • Patel M.R.
        • Peterson E.D.
        • Dai D.
        • Brennan J.M.
        • Redberg R.F.
        • Anderson H.V.
        • Brindis R.G.
        • Douglas P.S.
        Low diagnostic yield of elective coronary angiography.
        N Engl J Med. 2010; 362: 886-895
        • Wijeysundera H.C.
        • Bennell M.C.
        • Qiu F.
        • Ko D.T.
        • Tu J.V.
        • Wijeysundera D.N.
        • Austin P.C.
        Comparative-effectiveness of revascularization versus routine medical therapy for stable ischemic heart disease: a population-based study.
        J Gen Intern Med. 2014; 29: 1031-1039
        • Austin P.C.
        A tutorial and case study in propensity score analysis: an application to estimating the effect of in-hospital smoking cessation counseling on mortality.
        Multivariate Behav Res. 2011; 46: 119-151
        • Austin P.C.
        • Schuster T.
        The performance of different propensity score methods for estimating absolute effects of treatments on survival outcomes: a simulation study.
        Stat Methods Med Res. 2014; (http://dx.doi.org/10.1177/0962280213519716)
        • Cole S.R.
        • Hernan M.A.
        Adjusted survival curves with inverse probability weights.
        Comput Methods Programs Biomed. 2004; 75: 45-49
        • Abdallah M.S.
        • Spertus J.A.
        • Nallamothu B.K.
        • Kennedy K.F.
        • Arnold S.V.
        • Chan P.S.
        Clinical symptoms and angiographic findings of patients undergoing elective coronary angiography without prior stress testing.
        Am J Cardiol. 2014; 114: 348-354
        • Lin G.A.
        • Lucas F.L.
        • Malenka D.J.
        • Skinner J.
        • Redberg R.F.
        Mortality in Medicare patients undergoing elective percutaneous coronary intervention with or without antecedent stress testing.
        Circ Cardiovasc Qual Outcomes. 2013; 6: 309-314
        • Boden W.E.
        • O'Rourke R.A.
        • Teo K.K.
        • Hartigan P.M.
        • Maron D.J.
        • Kostuk W.J.
        • Knudtson M.
        • Dada M.
        • Casperson P.
        • Harris C.L.
        • Chaitman B.R.
        • Shaw L.
        • Gosselin G.
        • Nawaz S.
        • Title L.M.
        • Gau G.
        • Blaustein A.S.
        • Booth D.C.
        • Bates E.R.
        • Spertus J.A.
        • Berman D.S.
        • Mancini G.B.
        • Weintraub W.S.
        • COURAGE Trial Research Group
        Optimal medical therapy with or without PCI for stable coronary disease.
        N Engl J Med. 2007; 356: 1503-1516